AR and prostate carcinoma: For example, a study [5] on prostate cancer found that the UBE2C oncogene interacts with two distal binding sites of Androgen Receptor (AR, an important protein in prostate cancer) only in Castration-Resistant Prostate Cancer (CRPC) cells but not in Androgen-Dependent Prostate Cancer (ADPC) cells.